Pharmaceutical composition and uses thereof

Combining antithrombosis drugs and flavonoids like baicalein with blood pressure medications effectively reduces misfolded alpha-synuclein proteins, addressing the ineffectiveness of current treatments for neurodegenerative diseases and improving cognitive symptoms in patients with synucleinopathies.

WO2024263638A2PCT designated stage expired Publication Date: 2024-12-26YEEFAN MED INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/034614
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-20
Filing Date
2024-06-19
Publication Date
2024-12-26

Smart Images

  • Figure US2024034614_26122024_PF_FP_ABST
    Figure US2024034614_26122024_PF_FP_ABST
Patent Text Reader

Abstract

Described herein are pharmaceutical compositions and methods for treating, detecting, characterizing, and reducing misfolding proteins and preventing related diseases such as neurodegenerative diseases and normal aging.
Need to check novelty before this filing date? Find Prior Art